Modulating the Progression in IgA Nephropathy

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Nephron Clinical Practice

• Publication date

  2006-06-02

• Fields of study

  Medicine

• Identifiers
  DOI 10.1159/000093672PMID 16741372
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Mycophenolate mofetil alleviates persistent proteinuria in IgA nephropathy.

  2005cited by this paper
• Activation of tubular epithelial cells by mesangial-derived TNF-alpha: glomerulotubular communication in IgA nephropathy.

  2005cited by this paper
• Hematuria and proteinuria in a mass school urine screening test

  2005cited by this paper
• A randomized controlled trial of mycophenolate mofetil in patients with IgA nephropathy [ISRCTN62574616]

  2004cited by this paper
• Mycophenolate mofetil in IgA nephropathy: results of a 3-year prospective placebo-controlled randomized study.

  2004cited by this paper
• Use of corticosteroids, other immunosuppressive therapies, and tonsillectomy in the treatment of IgA nephropathy.

  2004cited by this paper
• Treatment of primary IgA nephropathy.

  2004cited by this paper
• IgA nephropathy: an update

  2004cited by this paper
• Effects of co-administration of urokinase and benazepril on severe IgA nephropathy.

  2004cited by this paper
• Chemokine receptor CCR1 but not CCR5 mediates leukocyte recruitment and subsequent renal fibrosis after unilateral ureteral obstruction.

  2004cited by this paper
• The role of fish oil/omega-3 fatty acids in the treatment of IgA nephropathy.

  2004cited by this paper
• IgA-associated renal diseases: Antibodies to environmental antigens in sera and deposition of immunoglobulins and antigens in glomeruli

  2004cited by this paper
• Combined therapy of enalapril and losartan attenuates histologic progression in immunoglobulin A nephropathy

  2004cited by this paper
• A randomized trial of nicotinamide and vitamin E in children with recent onset type 1 diabetes (IMDIAB IX).

  2004cited by this paper
• Applicability of steroid therapy in 275 adult patients with IgA nephropathy determined using a histological scoring system and degree of proteinuria

  2004cited by this paper
• Mesangial expression of angiotensin II receptor in IgA nephropathy and its regulation by polymeric IgA1.

  2004cited by this paper
• Cohort Study of Advanced IgA Nephropathy: Efficacy and Limitations of Corticosteroids with Tonsillectomy

  2003cited by this paper
• Targeted Downregulation of Extracellular Nephrin in Human IgA Nephropathy

  2003cited by this paper
• Vitamin E therapy in IgA nephropathy: a double-blind, placebo-controlled study

  2003cited by this paper
• Effect of fluvastatin and dipyridamole on proteinuria and renal function in childhood IgA nephropathy with mild histological findings and moderate proteinuria.

  2003cited by this paper
• Treatment of IgA nephropathy with ACE inhibitors: a randomized and controlled trial.

  2003cited by this paper
• Inherited forms of IgA nephropathy.

  2003cited by this paper
• Steroid therapy reduces mesangial matrix accumulation in advanced IgA nephropathy.

  2003cited by this paper
• Polymeric IgA1 from patients with IgA nephropathy upregulates transforming growth factor-beta synthesis and signal transduction in human mesangial cells via the renin-angiotensin system.

  2003cited by this paper
• Crescentic, proliferative IgA nephropathy: clinical and histological response to methylprednisolone and intravenous cyclophosphamide.

  2003cited by this paper
• Association of the CD14 gene –159C polymorphism with progression of IgA nephropathy

  2003cited by this paper
• The efficacy of tonsillectomy on long-term renal survival in patients with IgA nephropathy.

  2003cited by this paper
• Cyclophosphamide Pulse Therapy in Advanced Progressive IgA Nephropathy

  2003cited by this paper
• Effect of losartan and amlodipine on proteinuria and transforming growth factor-beta1 in patients with IgA nephropathy.

  2003cited by this paper
• Interdependent effect of angiotensin‐converting enzyme and platelet‐activating factor acetylhydrolase gene polymorphisms on the progression of immunoglobulin A nephropathy

  2002cited by this paper
• Additive antiproteinuric effect of ACE inhibitor and losartan in IgA nephropathy

  2002cited by this paper
• Increased risk of end-stage renal disease in familial IgA nephropathy.

  2002cited by this paper
• CD44 expression in IgA nephropathy.

  2002cited by this paper
• Short-term effects of fish oil treatment on urinary excretion of high- and low-molecular weight proteins in patients with IgA nephropathy.

  2002cited by this paper
• Prognostic Value of Urinary Interleukin 6 in Patients with IgA Nephropathy: An 8-Year Follow-Up Study

  2002cited by this paper
• INFLUENCE OF THE ENDOTHELIAL NITRIC OXIDE SYNTHASE POLYMORPHISM ON THE PROGRESSION OF AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE AND IgA NEPHROPATHY

  2002cited by this paper
• J Am Soc Nephrol 13: 2309–2319, 2002 Characteristics of Polymeric �-IgA Binding to Leukocytes in

  2002cited by this paper
• INFLUENCE OF THE ENDOTHELIAL NITRIC OXIDE SYNTHASE POLYMORPHISM ON THE PROGRESSION OF AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE AND IgA NEPHROPATHY

  2002cited by this paper
• Podocytopenia and disease severity in IgA nephropathy.

  2002influential reference
• Characteristics of polymeric lambda-IgA binding to leukocytes in IgA nephropathy.

  2002cited by this paper
• Regression of IgA nephropathy: a repeat biopsy study.

  2002influential reference
• IgA nephropathy.

  2002cited by this paper
• Serum IgA/C3 Ratio May Predict Diagnosis and Prognostic Grading in Patients with IgA Nephropathy

  2002cited by this paper
• A randomized trial of high-dose compared with low-dose omega-3 fatty acids in severe IgA nephropathy.

  2001cited by this paper
• Epidemiology of Cutaneous Melanoma in Germany and Worldwide

  2001cited by this paper
• IgA nephropathy: multivariate statistical analysis aimed at predicting outcome.

  2001cited by this paper
• Natural history of idiopathic IgA nephropathy: role of clinical and histological prognostic factors.

  2000cited by this paper
• Urinary Podocytes for the Assessment of Disease Activity in Lupus Nephritis

  2000cited by this paper
• Urinary excretion of podocytes in patients with diabetic nephropathy.

  2000cited by this paper
• The Long-Term Outcome of Patients with IgA Nephropathy Treated with Fish Oil in a Controlled Trial

  1999cited by this paper
• Combined therapy with prednisolone, azathioprine, heparin-warfarin, and dipyridamole for paediatric patients with severe IgA nephropathy--is it relevant for adult patients?

  1999influential reference
• The long-term outcome of patients with IgA nephropathy treated with fish oil in a controlled trial. Mayo Nephrology Collaborative Group.

  1999cited by this paper
• Inhibition of activated human mesangial cell proliferation by the natural product of Cordyceps sinensis (H1-A): an implication for treatment of IgA mesangial nephropathy.

  1999cited by this paper
• Podocyte number predicts long-term urinary albumin excretion in Pima Indians with Type II diabetes and microalbuminuria

  1999cited by this paper
• Effects of Fish Oil and α-Tocopherol in Immunoglobulin A Nephropathy in the Rat

  1998cited by this paper
• The antiproteinuric effect of angiotensin antagonism in human IgA nephropathy is potentiated by indomethacin.

  1998cited by this paper
• Effects of fish oil and alpha-tocopherol in immunoglobulin A nephropathy in the rat.

  1998cited by this paper
• Detection of Apoptotic Cells in Glomeruli of Patients with IgA Nephropathy

  1998cited by this paper
• Glomerulosclerosis in the remnant kidney rat is modulated by dietary alpha-tocopherol.

  1998cited by this paper
• Glomerular FcαR expression and disease activity in IgA nephropathy

  1997cited by this paper
• Glomerular Fc alphaR expression and disease activity in IgA nephropathy.

  1997cited by this paper
• Fish oil therapy for IgA nephropathy: efficacy and interstudy variability.

  1997cited by this paper
• Predicting renal outcome in IgA nephropathy.

  1997cited by this paper
• Future Directions in the Treatment of IgA Nephropathy

  1997cited by this paper
• Apoptosis in glomerular sclerosis.

  1996cited by this paper
• Genetically selected cardiomyocytes from differentiating embronic stem cells form stable intracardiac grafts.

  1996cited by this paper
• Vitamin E Ameliorates Renal Injury in an Experimental Model of Immunoglobulin A Nephropathy1

  1996cited by this paper
• Role of the deletion of polymorphism of the angiotensin converting enzyme gene in the progression and therapeutic responsiveness of IgA nephropathy.

  1995cited by this paper
• Dietary vitamin E supplementation ameliorates renal injury in chronic puromycin aminonucleoside nephropathy.

  1995cited by this paper
• A controlled trial of fish oil in IgA nephropathy. Mayo Nephrology Collaborative Group.

  1994influential reference
• Endothelin (ET)-3 stimulates cyclic guanosine 3',5'-monophosphate production via ETB receptor by producing nitric oxide in isolated rat glomerulus, and in cultured rat mesangial cells.

  1994cited by this paper
• Induction of nitric oxide synthase by cyclic AMP in rat vascular smooth muscle cells.

  1994cited by this paper
• Pathogenesis of IgA nephropathy: In vitro activation of human mesangial cells by IgA immune complex leads to cytokine secretion

  1994cited by this paper
• Fc alpha R expression on polymorphonuclear leukocyte and superoxide generation in IgA nephropathy.

  1994cited by this paper
• Fcα R expression on polymorphonuclear leukocyte and superoxide generation in IgA nephropathy

  1994cited by this paper
• Angiotensin II local hyperreactivity in the progression of IgA nephropathy.

  1993cited by this paper
• Therapy in IgA nephropathy.

  1993cited by this paper
• Taurine attenuates renal disease in chronic puromycin aminonucleoside nephropathy.

  1992cited by this paper
• Reactive oxygen molecules, oxidant injury and renal disease

  1991cited by this paper
• The role of free radicals in the progression of renal disease.

  1991cited by this paper
• Increased incidence of epistaxis in adolescents with familial hypercholesterolemia treated with fish oil.

  1990cited by this paper
• Plasma exchange in progressive IgA nephropathy

  1990cited by this paper
• The effect of fish-oil dietary supplement on the progression of mesangial IgA glomerulonephritis.

  1990cited by this paper
• Induction of renal growth and injury in the intact rat kidney by dietary deficiency of antioxidants.

  1990cited by this paper
• Oxygen consumption and oxidant stress in surviving nephrons.

  1990cited by this paper
• Radical-induced inactivation of kidney Na+,K(+)-ATPase: sensitivity to membrane lipid peroxidation and the protective effect of vitamin E.

  1990cited by this paper
• Dietary deficiency of antioxidants exacerbates ischemic injury in the rat kidney.

  1990cited by this paper
• Role of reactive oxygen metabolites in experimental glomerular disease.

  1989cited by this paper
• Role of reactive oxygen metabolites in experimental glomerular disease

  1989cited by this paper
• Evidence suggesting a role for hydroxyl radical in puromycin aminonucleoside-induced proteinuria.

  1988cited by this paper
• Remnant kidney hypermetabolism and progression of chronic renal failure.

  1988cited by this paper
• Worldwide perspective of IgA nephropathy.

  1988cited by this paper
• Tubular hypermetabolism as a factor in the progression of chronic renal failure.

  1988cited by this paper
• The commonest glomerulonephritis in the world: IgA nephropathy.

  1987cited by this paper
• Reactive oxygen species: production and role in the kidney.

  1986cited by this paper
• [IgA nephropathy].

  1985cited by this paper
• Oxygen free radicals in ischemic acute renal failure in the rat.

  1984cited by this paper
• Light emission by isolated rat glomeruli in response to phorbol myristate acetate.

  1981cited by this paper
• [Intercapillary deposits of IgA-IgG].

  1968cited by this paper

• Early secretory antigenic target 6 and culture filtrate protein 10 as diagnostic indicators in IgA nephropathy associated with renal tuberculosis

  2020cites this paper
• Nefropatía por inmunoglobulina A en pediatría, desenlaces clínicos con diferentes esquemas de manejo

  2020cites this paper
• Omega-3 Polyunsaturated Fatty Acids for the Treatment of IgA Nephropathy

  2017cites this paper
• Clinical Characteristics of Concomitant Nephrotic IgA Nephropathy and Minimal Change Disease in Children

  2015cites this paper
• Clinical Spectrum and Outcome of Childhood IgA Nephropathy - A Single Centre Experience

  2015cites this paper
• Outcome results in children with IgA nephropathy: a single center experience

  2012influential citation
• Comparison of inhibitors of renin–angiotensin–aldosterone system (RAS) and combination therapy of steroids plus RAS inhibitors for patients with advanced immunoglobulin A nephropathy and impaired renal function

  2012cites this paper
• n-3 polyunsaturated fatty acids and autoimmune-mediated glomerulonephritis.

  2010cites this paper
• Effects of Cyclosporin A Therapy Combined with Steroids and Angiotensin Converting Enzyme Inhibitors on Childhood IgA Nephropathy

  2010cites this paper
• Treatment of Severe Henoch-Schoenlein Purpura Nephritis in Children

  2010cites this paper
• Autoimmune dysfunction and subsequent renal insufficiency in a collegiate female athlete: a case report.

  2010cites this paper
• Paraneoplastic glomerular diseases and malignancies.

  2009cites this paper
• Insulin resistance, inflammatory markers and alcohol consumption in IgA glomerulonephritis

  2009influential citation
• The non-invasive biopsy--will urinary proteomics make the renal tissue biopsy redundant?

  2009cites this paper
• Behçet’s disease complicated by IgA nephropathy with nephrotic syndrome

  2008cites this paper
• Ten-year review of disease pattern from percutaneous renal biopsy: an experience from a paediatric tertiary renal centre in Hong Kong.

  2008cites this paper
• MPO-ANCA-positive IgA nephropathy successfully treated with tonsillectomy

  2007cites this paper
• Virtual Commons - Bridgewater State University Virtual Commons - Bridgewater State University

  year unknowncites this paper